title: [Sclerotherapy of idiopatic hydrocele with polidocanol: a study about 190 cases].
abstract: OBJECTIVE
  To evaluate the efficacy and side-effects of Polidocanol used as sclerosing agent for testicular hydrocele.
  
  
  METHODS
  One hundred and ninety men, with a median age of 55,9 years (40-89), treated for idiopatic hydrocele were assessed. After puncture and aspiration, the empty sac was instilled with 3% Polidocanol. We recorded recurrence, complications and associated pain on a visual analogue scale.
  
  
  RESULTS
  With a median follow-up of 19 months, The cure rate of hydroceles after one sclerotherapy session was 62,1%, and the overall cure rate using the procedure was 82,6%. Re-instillation was done for recurrences in 41% of patients. Polidocanol therapy was almost pain-free. A low rate of complications was observed.
  
  
  CONCLUSIONS
  Polidocanol is a useful sclerosing agent for treating testicular hydrocele. Due to its ease of administration, low frequency of complications, high rate of effectiveness, and excellent tolerability; we recommend sclerotherapy with polidocanol as the primary treatment for hydroceles.
authors.affiliation: Universite Tunis, El Manar, Tunisie.
authors.forename: Sataa
authors.initials: S
authors.lastname: Sallami
authors.forename: Mohamed Yassine
authors.initials: MY
authors.lastname: Binous
authors.forename: Sami
authors.initials: S
authors.lastname: Ben Rhouma
authors.forename: Mohamed
authors.initials: M
authors.lastname: Chelif
authors.forename: Mohamed
authors.initials: M
authors.lastname: Hmidi
authors.forename: Yasssine
authors.initials: Y
authors.lastname: Nouira
authors.forename: Nawfel
authors.initials: N
authors.lastname: Ben Rais
authors.forename: Ali
authors.initials: A
authors.lastname: Horchani
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000009:adverse effects / Q000627:therapeutic use*; D012597:Sclerosing Solutions / Q000009:adverse effects / Q000627:therapeutic use; D015911:Sclerotherapy / Q000009:adverse effects / Q000379:methods*; D006848:Testicular Hydrocele / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols